Multimodal Imaging

Global Multimodal Imaging Market to Reach US$3.5 Billion by 2030

The global market for Multimodal Imaging estimated at US$2.8 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.0% over the analysis period 2024-2030. PET / CT Systems, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the SPECT / CT Systems segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$723.4 Million While China is Forecast to Grow at 6.6% CAGR

The Multimodal Imaging market in the U.S. is estimated at US$723.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$764.7 Million by the year 2030 trailing a CAGR of 6.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 3.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.7% CAGR.

Global Multimodal Imaging Market - Key Trends and Drivers Summarized

How Is Multimodal Imaging Transforming Diagnostic Techniques?

Multimodal imaging combines different imaging modalities to provide more comprehensive information about tissues or organs. This approach enhances diagnostic accuracy by integrating the strengths of each modality, such as combining anatomical detail from MRI with functional data from PET or CT scans. It is used extensively in oncology for tumor detection and monitoring, neurology for brain mapping, and cardiology for evaluating heart function. The technology allows clinicians to gain insights that single-modal imaging cannot provide, such as correlating anatomical structures with metabolic activity, which is crucial for early disease detection and treatment planning. With advancements in imaging technologies, multimodal imaging is moving beyond clinical diagnostics to include areas such as research and drug development. It is being applied in preclinical studies to better understand disease mechanisms and assess the effectiveness of new therapies. Multimodal imaging`s ability to fuse data from different sources makes it an essential tool for complex cases, where a more detailed and holistic view of the patient`s condition is necessary. The technology also supports personalized medicine, allowing for tailored treatment plans based on the specific characteristics of a patient`s disease.

What Trends Are Influencing the Multimodal Imaging Market?

Several trends are driving the adoption of multimodal imaging, including the growing prevalence of chronic diseases, technological advancements in imaging modalities, and the increasing focus on precision medicine. The rise in chronic conditions such as cancer, cardiovascular diseases, and neurological disorders has led to a greater need for accurate diagnostic tools, boosting the demand for multimodal imaging. The integration of AI and machine learning in image processing is further enhancing the capabilities of multimodal imaging, enabling automated image analysis and more precise diagnosis. There is also a trend towards hybrid imaging systems, which integrate multiple modalities in a single machine, such as PET/CT or PET/MRI scanners. These systems provide comprehensive diagnostic data, leading to faster and more efficient clinical workflows. In research, multimodal imaging is increasingly used for studying disease progression and evaluating treatment efficacy. Moreover, government funding and grants for healthcare research and development are facilitating the adoption of advanced imaging technologies in hospitals and research institutions.

How Do Segments Impact the Multimodal Imaging Market?

Modality segments include PET/CT, PET/MRI, SPECT/CT, and other combinations. PET/CT holds the largest market share due to its wide use in oncology for tumor detection and therapy monitoring. PET/MRI is also gaining popularity, especially in neurology and pediatrics, for its ability to provide both functional and structural information with reduced radiation exposure. The market is segmented by application into oncology, cardiology, neurology, and others, with oncology being the largest segment. End-users of multimodal imaging include hospitals, diagnostic imaging centers, and research institutions. Hospitals dominate the market due to the high volume of imaging procedures performed in these settings. Geographically, North America leads the market, driven by advanced healthcare infrastructure and high adoption rates of new technologies. Europe follows, with significant investments in healthcare and research, while the Asia-Pacific region is experiencing rapid growth due to increasing healthcare expenditure and expanding medical imaging applications.

What Factors Are Driving the Growth in the Multimodal Imaging Market?

The growth in the multimodal imaging market is driven by several factors, including the rising prevalence of chronic diseases, technological advancements in imaging modalities, and increasing investments in healthcare infrastructure. The demand for precise diagnostic tools for cancer, cardiovascular diseases, and neurological disorders is boosting the adoption of multimodal imaging. Technological innovations, such as the integration of AI in imaging software, are further enhancing diagnostic accuracy, supporting market growth. Moreover, the trend towards precision medicine and personalized treatment plans is driving the use of multimodal imaging, as it provides comprehensive data that can guide therapeutic decisions.

SCOPE OF STUDY:

The report analyzes the Multimodal Imaging market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Technology (PET / CT Systems, SPECT / CT Systems, PET / MR Systems, OCT / Fundus Imaging Systems, Other Technologies); Application (Oncology, Cardiology, Brain & Neurology, Ophthalmology, Other Applications); End-Use (Hospitals, Diagnostic Imaging Centers, Other End-Uses)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 42 Featured) -

• Canon Medical Systems Corporation
• Carl Zeiss AG
• GE Healthcare
• Heidelberg Engineering
• Infraredx, Inc.
• Koninklijke Philips N.V.
• Mediso Medical Imaging Kft
• MILabs B.V.
• Neusoft Medical Systems Co., Ltd.
• Northridge Tri-Modality Imaging, Inc.
• PerkinElmer, Inc.
• Shanghai United Imaging Healthcare Co., Ltd.
• Siemens Healthineers
• Spectrum Dynamics Medical
• Topcon Corporation
• United Imaging Healthcare Co., Ltd.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.